Items where Author is "Freeman, Jane"
Number of items: 24.
Article
Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model. (2023)
Perezimor Etifa,
César Rodríguez,
Céline Harmanus,
Ingrid M. J. G. Sanders,
Igor A. Sidorov,
Olufunmilayo A. Mohammed,
Emily Savage,
Andrew R. Timms,
Jane Freeman,
Wiep Klaas Smits,
Mark H. Wilcox
and
Simon D. Baines
![]()
Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model. (2014)
Grace S. Crowther,
Caroline H. Chilton,
Sharie L. Todhunter,
Scott Nicholson,
Jane Freeman,
Simon D. Baines
and
Mark H. Wilcox
Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota. (2014)
Grace S. Crowther,
Caroline H. Chilton,
Sharie L. Todhunter,
Scott Nicholson,
Jane Freeman,
Simon D. Baines
and
Mark H. Wilcox
![]()
Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease. (2013)
David W. Eyre,
A. Sarah Walker,
Jane Freeman,
Simon D. Baines,
Warren N. Fawley,
Caroline H. Chilton,
David Griffiths,
Alison Vaughan,
Derrick W. Crook,
Tim E. A. Peto
and
Mark H. Wilcox
![]()
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection. (2013)
Grace S Crowther,
Simon D. Baines,
Sharie L Todhunter,
Jane Freeman,
Caroline H Chilton
and
Mark H Wilcox
Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model. (2013)
Simon D. Baines,
Caroline H. Chilton,
Grace S. Crowther,
Sharie L. Todhunter,
Jane Freeman
and
Mark H. Wilcox
Mixed infection by Clostridium difficile in an in vitro model of the human gut. (2013)
Simon D. Baines,
Grace S. Crowther,
Sharie L. Todhunter,
Jane Freeman,
Caroline H. Chilton,
Warren N. Fawley
and
Mark H. Wilcox
Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model. (2011)
Simon D. Baines,
Alan R. Noel,
Grace S. Huscroft,
Sharie L. Todhunter,
Rachael O'Connor,
Joanne K. Hobbs,
Jane Freeman,
Andy M. Lovering
and
M. H. Wilcox
Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole. (2011)
Jane Freeman,
Simon D. Baines,
Sharie L. Todhunter,
Grace S. Huscroft
and
M. H. Wilcox
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model. (2009)
Simon D. Baines,
Rachel O'Connor,
Katie Saxton,
Jane Freeman
and
M. H. Wilcox
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model. (2009)
Katie Saxton,
Simon D. Baines,
Jane Freeman,
Rachael O'Connor
and
M. H. Wilcox
Mecillinam : a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model. (2009)
Simon D. Baines,
Rachael O'Connor,
Grace Huscroft,
Katie Saxton,
Jane Freeman
and
Mark H Wilcox
Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection. (2009)
Simon D. Baines,
Jane Freeman
and
M. H. Wilcox
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model. (2008)
Simon D. Baines,
Rachael O'Connor,
Katie Saxton,
Jane Freeman
and
Mark H. Wilcox
Emergence of reduced susceptibility to metronidazole in Clostridium difficile. (2008)
Simon D. Baines,
Rachael O'Connor,
Jane Freeman,
Warren N Fawley,
Celine Harmanus,
Paola Mastrantonio,
Ed J. Kuijper
and
M. H. Wilcox
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin. (2008)
Rachael O'Connor,
Simon D. Baines,
Jane Freeman
and
Mark H. Wilcox
Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model. (2007)
Jane Freeman,
Simon D. Baines,
Katie Saxton
and
Mark H. Wilcox
Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. (2007)
Warren N Fawley,
Sarah Underwood,
Jane Freeman,
Simon D. Baines,
Katie Saxton,
Keith Stephenson,
Robert C. Owens
and
M. H. Wilcox
![]()
Measurement of toxin production by Clostridium difficile. (2006)
Jane Freeman,
Warren Fawley,
Simon D. Baines
and
Mark Wilcox
Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model. (2006)
Simon D. Baines,
Katie Saxton,
Jane Freeman
and
Mark H. Wilcox
Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital. (2005)
Jane Freeman,
Joanna Stott,
Simon D. Baines,
Warren N. Fawley
and
Mark H. Wilcox
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. (2005)
Jane Freeman,
Simon D. Baines,
Daniela Jabes
and
Mark H. Wilcox
Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model. (2005)
Simon D. Baines,
Jane Freeman
and
Mark H. Wilcox